NEW YORK-Wednesday 18 December 2019 [ AETOS Wire ]
(BUSINESS WIRE)-- The Estée Lauder Companies Inc.
(NYSE: EL) announced today that it has completed its acquisition of
Have & Be Co. Ltd., the Seoul-based, global skin care company behind
Dr. Jart+ and men’s grooming brand Do The Right Thing.
Founded in 2005 by ChinWook Lee in
Seoul, South Korea, Dr. Jart+ is a high-growth, global skin care brand
fueled by cutting-edge innovation that offers a wide variety of
high-performing skin care products. With a unique combination of
dermatological science and art – as is reflected in the brand name,
which is inspired by the phrase “Doctor Joins Art” – Dr. Jart+ appeals
to a broad range of consumers and has a devoted following among
millennials in Asia and the United States.
Best known for its high-quality,
on-trend skin care collections such as Cicapair and Ceramidin, the brand
is renowned for its outstanding and fast-moving innovation pipeline and
rapid speed-to-market capabilities. Sold through specialty-multi
channels, travel retail, freestanding stores, high-end department stores
and e-commerce sites in more than 35 countries globally, the brand
offers a wide range of high-quality moisturizers, masks, cleansers and
serums that are beloved for their innovative, breakthrough formulations.
About The Estée Lauder Companies Inc.
The Estée Lauder Companies Inc.
is one of the world’s leading manufacturers and marketers of quality
skin care, makeup, fragrance and hair care products. The Company’s
products are sold in over 150 countries and territories under brand
names including: Estée Lauder, Aramis, Clinique, Prescriptives, Lab
Series, Origins, Tommy Hilfiger, M·A·C, Kiton, La Mer, Bobbi Brown,
Donna Karan New York, DKNY, Aveda, Jo Malone London, Bumble and bumble,
Michael Kors, Darphin, Tom Ford, Smashbox, Ermenegildo Zegna, AERIN,
RODIN olio lusso, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW,
By Kilian, BECCA, Too Faced and Dr. Jart+.
ELC-C
ELC-F
ELC-F
View source version on businesswire.com: https://www.businesswire.com/news/home/20191217005915/en/
Contacts
Investor Relations:
Rainey Mancini
(212) 284-3049
Rainey Mancini
(212) 284-3049
Media Relations:
Jill Marvin
(212) 572-4438
Jill Marvin
(212) 572-4438
